Impact BioMedical's Linebacker and Equivir inhibit SARS-CoV-2, virus responsible for the COVID-19 outbreak
- Written by ACN Newswire - Press Releases
SINGAPORE, Mar 18, 2020 - (ACN Newswire) - SGX-listed Singapore eDevelopment Ltd (SeD; SGX:40V) has announced that its wholly-owned U.S. biomedical subsidiary Impact BioMedical, Inc. has through its scientific research partner GRDG Sciences, LLC. conducted molecular docking studies utilizing advanced computational models, indicating that its
Read more //?#